Institution
Hospital Universitario de Fuenlabrada
- 42running trials
- 18closed trials
- 3,695publications (OpenAlex)
Running trials
Recruiting
Not yet recruiting
Recruiting
Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight
Recruiting
Recruiting
Recruiting
Recruiting
Not yet recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
Recruiting
Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease
Recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Recruiting
Recruiting
Active, not recruiting
OP-1250 (Palazestrant) vs. Standard of Care for the Treatment of ER+/HER2- Advanced Breast Cancer
Active, not recruiting
Recruiting
Active, not recruiting
Recruiting
Recruiting
Active, not recruiting
Recruiting
Recruiting
NDMM Patients Candidates for ASCT Comparing Extended VRD Plus vs. Isa-VRD vs. Isa-V-Iberdomide
Active, not recruiting
Recruiting
OSPREY is a Post-market, Global, Multicentre, Observational, Prospective Registry.
Recruiting
Recruiting
Clinical Trial on HIPEC With Mitomycin C in Colon Cancer Peritoneal Metastases (GECOP-MMC)
Active, not recruiting
Active, not recruiting
Sacituzumab Govitecan in Primary HER2-negative Breast Cancer
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Recruiting
Computerized Registry of Patients With Venous Thromboembolism (RIETE)
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Crohn's disease3 recruiting
- Lung cancer3 recruiting
- Asthma2 recruiting
- Deep vein thrombosis and pulmonary embolism2 recruiting
- Ulcerative colitis2 recruiting
- Chronic rhinosinusitis with nasal polyps1 recruiting
- Colorectal cancer1 recruiting
- Metastatic breast cancer1 recruiting
- Multiple myeloma1 recruiting
- Obesity1 recruiting
- Osteoarthritis1 recruiting
- Pancreatic cancer1 recruiting
- Triple-negative breast cancer1 recruiting
Closed trials
Completed
Completed
Active, not recruiting
Afimkibart (RO7790121) for the Treatment of Moderate to Severe Active Crohn's Disease
Completed
ABTECT-2 - ABX464 Treatment Evaluation for Ulcerative Colitis Therapy -2
Active, not recruiting
Once Daily Versus Twice Daily Budesonide Orodispersible Tablets for Induction of Remission in EoE
Completed
Phase 3 Study to Evaluate the Safety and Efficacy of Hydrocortisone Acetate Suppositories
Completed
Palbociclib and Binimetinib in Advanced Triple Negative Breast Cancer
Completed
Impact of Telemonitoring in the Management of Complex IBD in Spain: M-TECCU
Completed
Completed
Long-term Follow-up Study With Darvadstrocel in the Treatment of Complex Perianal Fistula
Completed
Completed
Completed
A Study of Baricitinib (LY3009104) in Participants With Rheumatoid Arthritis
Completed
Completed
Filgotinib in Long-Term Extension Study of Adults With Ulcerative Colitis
Completed
Completed
Completed
Registry name variants (10)
Trial registries list this institution under these names. Each row is one registry entry: its address and the trials registered under it.
Hospital Universitario de Fuenlabrada
Fuenlabrada, Madrid 28942
47 trials
Hospital Universitario de Fuenlabrada
Madrid, 28942
9 trials
Hospital Universitario de Fuenlabrada
Fuenlabrada, Madrid 28942
1 trial
Hospital Universitario de Fuenlabrada
Fuenlabrada, Madrid 28942
1 trial
Hospital Universitario de Fuenlabrada. Servicio de Oncología
Fuenlabrada, Madrid 28942
1 trial
Hospital Universitario Fuenlabrada
Madrid
1 trial
NCT06970977CRS Questionnaire Validation Project
Contact: Ithzel María Villareal
HOSPITAL UNIVERSITARIO DE FUENLABRADA (Coordinating Centre)
Fuenlabrada, Madrid 28942
Hospital Universitario de Fuenlabrada
Fuenlabrada, Madrid 28942
Hospital Universitario de Fuenlabrada
Fuenlabrada, Madrid 28942
Hospital Universitario de Fuenlabrada
Fuenlabrada, Madrid 28942
Conditions
Diseases this institution publishes on or runs trials for.
- Eosinophilic oesophagitis4 works · 1 trial
Institution data: ROR 04scbtr44 (CC0-1.0)Updated 15 Nov 2026